跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALVESCO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ALVESCO
Authorized
STANDARD
ALVESCO
Covis Pharma GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bec28a2be71eb616
Company
Covis Pharma GmbH
Type
Standard
Approval Details
Approval Id
bec28a2be71eb616
Drug Approval Canada Name
ALVESCO
Product Name
ALVESCO
Status
Marketed
Status Date
2021-02-10
Original Market Date
2006-09-27
Din
02285614
Drug Class
Human
Dosage Form
Aerosol, Metered Dose
Route Of Administration
Inhalation
Schedule
Prescription
Ahfs
68:04.00
Atc Original
R03BA08 CICLESONIDE
Atc Name
r 03 ba 08
Aig Number
0151669002
Company Name
Covis Pharma GmbH
Company Address
Grafenauweg 12, Zug, Zug, Switzerland, 6300
Company Detail Path
/organization/covis-pharma-gmbh
Company Information
Pharmaceutical Company Name
Covis Pharma GmbH
Country Name
Switzerland
Province Name
Zug
City Name
zug,zug,country_ch
Address
Grafenauweg 12
Active Ingredients
CICLESONIDE
200 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bec28a2be71eb616
Type
Standard
Back to Health Canada Approvals